| 纤溶酶联合血塞通注射液治疗急性脑梗死临床研究 |
| |
| 引用本文： | 张永香,李志强.纤溶酶联合血塞通注射液治疗急性脑梗死临床研究[J].中国医药,2010,5(1):617-618. |
| |
| 作者姓名： | 张永香 李志强 |
| |
| 作者单位： | 新乡医学院第一附属医院药剂科,河南省卫辉市,453100; |
| |
| 摘 要： | Objective To explore the total curative effects of Xuesaitong injection combined whth fibrinogenase on acute cerebral infarction(ACI). Methods One hundred and twelve patients with ACI were randomly and equally divided into two groups, 56 cases in the treatment group were treated with Xuesaitong injection combined Fibrinogenase, while 56 cases in the control group were treated with compound danshen injection, once a day for 15days. Results Coagulation indicators of the treatment group was obviously better than that of the control group(P ＜0.05 or P ＜ 0.01 ). The total effective rate (91.1% ) of the treatment group was obviously higher than that of the control group( 69.6% )( P＜ 0.05 ). The Neurological deficit scores of therapy group were significantly improved (P ＜ 0.05). There was no obvious adverse reaction. Conclusion Xuesaitong injection combined fibrinogenase are remarkablyeffective and safe in treating ACI.
|
| 关 键 词： | 脑梗死 纤溶酶 血塞通注射液 |
Clinical study of Xuesaitong injection combined whih fibrinogenase for acute cerebral infarction |
| |
| ZHANG Yong-xiang,LI Zhi-qiang.Clinical study of Xuesaitong injection combined whih fibrinogenase for acute cerebral infarction[J].China Medicine,2010,5(1):617-618. |
| |
| Authors: | ZHANG Yong-xiang LI Zhi-qiang |
| |
| Abstract: | |
| |
| Keywords: | Cerebral infarctionFibrinogenaseXuesaitong injection |
|
